4.5 Article

Overexpression of FOXO1 in skeletal muscle does not alter longevity in mice

期刊

MECHANISMS OF AGEING AND DEVELOPMENT
卷 130, 期 7, 页码 420-428

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.mad.2009.04.004

关键词

Calorie restriction; FOXO1; Longevity; Gadd 45 alpha; Glutamine synthase

资金

  1. Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo, Japan)
  2. Japanese Ministry of Health, Labour and Welfare
  3. Mitsui Sumitomo insurance Welfare Foundation
  4. Organization for Pharmaceutical Safety and Research (OPSR, Osaka, Japan)

向作者/读者索取更多资源

Caloric restriction (CR) is the most robust and reproducible intervention that can extend lifespan in rodents. Studies in invertebrates have led to the identification of genes that regulate lifespan, some of which encode components of the insulin or insulin-like signaling pathway, including DAF-16 (C. elegans) and dFOXO (Drosophila). Mice subjected to CR for 8 weeks showed an increase in FOXO1 mRNA and other longevity-related genes: Gadd 45 alpha, glutamine synthase, and catalase in skeletal muscle. To investigate whether FOXO1 expression affects longevity in mammals, transgenic mice were studied that overexpress FOXO1 in their skeletal muscle (FOXO1 mice), and in which muscle atrophy occurs. FOXO1 mice showed increases in Gadd 45(x, and glutamine synthase proteins in skeletal muscle. In FOXO1 mice, the phosphorylation/dephosphorylation state of the p70 S6K and 4E-BP1 proteins were not altered, suggesting that translation initiation of protein synthesis might not be suppressed. The lifespan of FOXO1 mice was similar to their wild-type littermates. FOXO1 overexpression could not prevent aging-induced reduction in catalase, CuZu-SOD, and Mn-SOD mRNA in skeletal muscle. These data suggest that an increase in FOXO1 protein and its activation in skeletal muscle does not extend lifespan in mice. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据